Inhibidores
Los inhibidores son moléculas que se unen a enzimas, receptores u otras proteínas para reducir o bloquear su actividad biológica. Estos compuestos se utilizan ampliamente en la investigación para estudiar vías biológicas, comprender los mecanismos de las enfermedades y desarrollar fármacos terapéuticos. Los inhibidores desempeñan un papel crucial en el tratamiento de diversas enfermedades, incluyendo el cáncer, las enfermedades cardiovasculares y las infecciones. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad para apoyar su investigación en bioquímica, biología celular y desarrollo farmacéutico.
Subcategorías de "Inhibidores"
- Angiogénesis(2.542 productos)
- Apoptosis(5.816 productos)
- Ciclo celular / Checkpoint(4.466 productos)
- Cromatina / Epigenética(2.252 productos)
- Señalización citoesquelética(1.381 productos)
- Daño al ADN / Reparación del ADN(2.830 productos)
- Endocrinología / Hormonas(3.518 productos)
- Enzima(3.640 productos)
- GPCR / proteína G(8.362 productos)
- Inmunología e inflamación(3.540 productos)
- Virus de la gripe(296 productos)
- Señalización JAK / STAT(405 productos)
- Señalización MAPK(1.201 productos)
- Transportador de membrana / canal de iones(2.809 productos)
- Metabolismo(9.462 productos)
- Microbiología / Virología(7.003 productos)
- Neurociencia(9.942 productos)
- Otros inhibidores(37.827 productos)
- Reducción de oxidación(40 productos)
- Señalización PI3K / Akt / mTOR(1.399 productos)
- Proteasas / Proteasoma(1.598 productos)
- Células madre y Derivados(830 productos)
- Tirosina quinasa / adaptadores(2.012 productos)
- Ubiquitinación(1.651 productos)
Mostrar 16 subcategorías más
Se han encontrado 66618 productos de "Inhibidores"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Carbonic anhydrase inhibitor 8
<p>R-13, a carbonic anhydrase inhibitor, has Ki of 60.7 nM (hCA I), 320.7 nM (hCA II), and 2298 nM (hCA IV).</p>Fórmula:C20H25N3O4SForma y color:SolidPeso molecular:403.5AChE/BChE-IN-1
<p>AChE/BChE-IN-1: dual AChE/BChE inhibitor, IC50 of 1.06 nM/7.3 nM, crosses blood-brain barrier, with antioxidant properties for Alzheimer's research.</p>Fórmula:C32H35ClN6O3Forma y color:SolidPeso molecular:587.11LMD-A
CAS:<p>LMD-A, also known as CCR8 antagonist LMD-A, is a CCR8 antagonist.</p>Fórmula:C27H32N4O4SForma y color:SolidPeso molecular:508.63FNDR-20123
<p>FNDR-20123: First safe, effective anti-malarial HDAC inhibitor for Plasmodium (IC50: 31 nM) & human HDACs, with nanomolar potency across several subtypes.</p>Fórmula:C21H24ClN5O2Forma y color:SolidPeso molecular:413.9PF-06380101
CAS:<p>PF-06380101, a potent auristatin analog and Dolastatin 10 derivative, shows strong anti-tumor activity and unique ADME attributes.</p>Fórmula:C39H62N6O6SPureza:98%Forma y color:SolidPeso molecular:743.01AAK1-IN-2 TFA
<p>AAK1-IN-2 TFA (compound (S)-31) is a selective and potent AAK1 inhibitor (IC50: 5.8 nM) that can cross the blood-brain barrier.</p>Fórmula:C24H22F6N4O4Forma y color:SolidPeso molecular:544.45Rivenprost
CAS:<p>Rivenprost, selective EP4 agonist (Ki: 0.7 nM), promotes bone growth, osteoblast differentiation, and aids wound healing.</p>Fórmula:C24H34O6SForma y color:SolidPeso molecular:450.59DDCPPB-Glu
CAS:<p>DDCPPB-Glu is a 6-5 fused ring heterocycle antifolate that shows antitumor activity.</p>Fórmula:C22H27N5O5Pureza:98%Forma y color:SolidPeso molecular:441.48SC-435 mesylate
CAS:<p>SC-435 is an ileal apical sodium co-dependent bile acid transporter (ASBT). SC-435 inhibits plasma cholesterol.</p>Fórmula:C37H59N3O7S2Pureza:98%Forma y color:SolidPeso molecular:722.01KY-02327 acetate
<p>KY-02327 acetate inhibits Dvl-CXXC5, stabilizes Wnt/β-catenin signaling, and enhances osteoblast differentiation.</p>Fórmula:C22H31N3O6Forma y color:SolidPeso molecular:433.5EGFR/HER2-IN-7
<p>EGFR/HER2-IN-7: Potent, selective dual inhibitor for MCF-7 cancer; IC50: EGFR 0.18μM, HER2 0.146μM, DHFR 0.907μM.</p>Fórmula:C19H21N3O2SForma y color:SolidPeso molecular:355.45Amrubicin HCl
CAS:<p>Amrubicin (SM-5887), an anthracycline, treats lung cancer by inhibiting DNA replication and topoisomerase II, with less cardiac toxicity.</p>Fórmula:C25H25NO9Forma y color:SolidPeso molecular:483.47Antitubercular agent-16
<p>Compound 5q is a potent antitubercular with low MIC90 values (0.40-23.51 μg/mL) against M. tuberculosis strains, showing minimal cytotoxicity.</p>Fórmula:C21H27N3SForma y color:SolidPeso molecular:353.52PARP10/15-IN-3
<p>Compound 8a, a dual PARP10 & PARP15 inhibitor, has IC50s: PARP10 at 0.14μM & PARP15 at 0.40μM; it's cell-permeable & anti-apoptotic.</p>Fórmula:C12H12N2O3Forma y color:SolidPeso molecular:232.24CCT369260
CAS:<p>CCT369260 (compound 1), an orally active inhibitor targeting B-cell lymphoma 6 (BCL6), demonstrates anti-tumor efficacy with an IC50 value of 520 nM [1].</p>Fórmula:C24H31ClF2N6O2Forma y color:SolidPeso molecular:508.99Vibegron
CAS:<p>Vibegron (MK-4618) is an effective and selective Beta 3 adrenergic receptor agonist, used to treat overactive bladder (OAB).</p>Fórmula:C26H28N4O3Forma y color:SolidPeso molecular:444.53COX-2-IN-7
<p>COX-2-IN-7: potent, orally active COX-2 inhibitor with higher selectivity than Celecoxib, IC50 6.585 uM, anti-inflammatory, low ulcer risk.</p>Fórmula:C15H13N3O2S2Forma y color:SolidPeso molecular:331.41LT-850-166
<p>LT-850-166 is a potent inhibitor of FLT3 and has shown efficacy in overcoming a wide range of FLT3 mutations.</p>Fórmula:C30H29Cl2N7OForma y color:SolidPeso molecular:574.5G-479
CAS:<p>G-479, a potent MEK inhibitor and improved analogue of GDC-0623, has distributed polarity enhancing bioactivity.</p>Fórmula:C16H15FIN5O4Forma y color:SolidPeso molecular:487.22YCW-E11
CAS:<p>YCW-E11 is an antiapoptotic Bcl-2 family proteins inhibitor.</p>Fórmula:C25H21Cl2N3O6S2Pureza:98%Forma y color:SolidPeso molecular:594.49M-89 MLL inhibitor
CAS:<p>M-89, a potent Menin-MLL blocker: Kd 1.4 nM, IC50 25 nM for MV4;11 cells, 55 nM for MOLM-13, >100x selective over HL-60.</p>Fórmula:C37H47N5O4SForma y color:SolidPeso molecular:657.87ABT-072
CAS:<p>ABT-072 is a nonnucleoside NS5B polymerase inhibitor and a candidate drug evaluated for treatment of hepatitis C virus.</p>Fórmula:C24H27N3O5SPureza:98%Forma y color:SolidPeso molecular:469.55(2S,4S)-Sacubitril
CAS:<p>(2S,4S)-Sacubitril (Sacubitril Impurity C) is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.</p>Fórmula:C24H29NO5Pureza:98%Forma y color:SolidPeso molecular:411.49L2H2-6OTD
CAS:<p>L2H2-6OTD is a telomerase inhibitor with G-quadruplex loops; IC50: 15 nM.</p>Fórmula:C30H30N10O8Forma y color:SolidPeso molecular:658.62(3S,4R)-Tofacitinib
CAS:(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM).Fórmula:C16H20N6OPureza:98%Forma y color:SolidPeso molecular:312.37Antibacterial agent 112
<p>Compound 112: Powerful antibacterial, MIC 1250 μM against B. subtilis, E. coli, E. faecalis, S. typhimurium, S. aureus; also an HIV-1 antibody.</p>Fórmula:C35H23N5O5Forma y color:SolidPeso molecular:593.59Ici D1542
CAS:Ici D1542: potent TXS inhibitor & TXA2 receptor antagonist, effective thromboxane blocker in vitro.Fórmula:C25H30N2O7Pureza:98%Forma y color:SolidPeso molecular:470.51Antitumor agent-43
<p>Antitumor agent-43 (Compound 4B) is a potent antitumor agent that induces cell cycle arrest at G2/M phase.</p>Fórmula:C16H8N2O3Forma y color:SolidPeso molecular:276.25Lipoxin A5
CAS:<p>LXA5 is made from EPA by leukocytes, contracts guinea pig lungs like LXA4/LXB4, but doesn't dilate aorta.</p>Fórmula:C20H30O5Forma y color:SolidPeso molecular:350.45Antibacterial agent 63
CAS:<p>Aztreonam-siderophore conjugate 63 is an antibacterial agent that exhibits efficacy against Gram-negative bacteria through the linkage of aztreonam to a</p>Fórmula:C35H43N9O14S2Forma y color:SolidPeso molecular:877.9Casuarinin
CAS:<p>Casuarinin, an ellagitannin found in pomegranates and certain Casuarina/Stachyurus plants, is a carbonic anhydrase inhibitor and astringent.</p>Fórmula:C41H28O26Forma y color:SolidPeso molecular:936.65SHP2 IN-1
CAS:<p>SHP2 IN-1 is an allergic SHP2 (PTPN11) inhibitor(IC50 : 3 nM).</p>Fórmula:C18H22Cl2N6OSPureza:98%Forma y color:SolidPeso molecular:441.3815(R)-Lipoxin A4
CAS:<p>Lipid-derived lipoxins are produced at the site of vascular and mucosal inflammation where they down-regulate polymorphonuclear leukocyte recruitment and</p>Fórmula:C20H32O5Forma y color:SolidPeso molecular:352.479(S),10(S),13(S)-TriHOME
CAS:<p>9(S),10(S),13(S)-TriHOME is an oxylipin derived from linoleic acid. It has been detected in beer and in bronchoalveolar lavage fluid (BALF) from female smokers.</p>Fórmula:C18H34O5Forma y color:SolidPeso molecular:330.46PIM1-IN-3
<p>PIM1-IN-3 (HL8) selectively blocks PIM1, induces Colo320 cell apoptosis, and may be researched for cancer.</p>Fórmula:C27H25BrN6OForma y color:SolidPeso molecular:529.43CN-716 HCl
CAS:<p>cn-716 is a novel Zika virus (ZIKV) NS2B-NS3pro protease inhibitor.</p>Fórmula:C22H33BCl2N6O4Forma y color:SolidPeso molecular:527.25CH-38083
CAS:<p>CH-38083 is a selective and effective alpha-2 adrenoceptors antagonist.</p>Fórmula:C18H24ClNO3Pureza:98%Forma y color:SolidPeso molecular:337.84Quinagolide hydrochloride
CAS:Quinagolide hydrochloride is a selective agonist of dopamine D2 receptor.Fórmula:C20H34ClN3O3SPureza:98%Forma y color:SolidPeso molecular:432.02Dyrk1A-IN-4
CAS:Dyrk1A-IN-4, compound 48, is an oral DYRK1A/DYRK2 inhibitor with IC50s: 2 nM (DYRK1A), 6 nM (DYRK2), anticancer properties.Fórmula:C14H13F3N6Forma y color:SolidPeso molecular:322.29VEGFR-2-IN-13
<p>VEGFR-2-IN-13 (Compound 19a) is a potent VEGFR-2 inhibitor (IC50: 3.4 nM). vEGFR-2-IN-13 arrests the HepG2 cell cycle in G2/M phase and induces apoptosis.</p>Fórmula:C24H18N6O2SForma y color:SolidPeso molecular:454.522-HDHA
CAS:<p>22-HDHA is an oxidation product of docosahexaenoic acid .</p>Fórmula:C22H32O3Forma y color:SolidPeso molecular:344.49Zaragozic acid C
CAS:<p>Zaragozic acid C is an effective inhibitor of squalene synthase.</p>Fórmula:C40H50O14Pureza:98%Forma y color:SolidPeso molecular:754.82AChE-IN-25
<p>AChE-IN-25: selective, potent AChE inhibitor, non-competitive, IC50 = 2.95 μM, for Alzheimer's research.</p>Fórmula:C20H15ClN4O4SForma y color:SolidPeso molecular:442.88ZINC000104379474
<p>ZINC000104379474 is a compound that targets SARS-CoV-2 endoribonuclease.</p>Fórmula:C27H33N3O10Forma y color:SolidPeso molecular:559.57RORγt/DHODH-IN-1
CAS:RORγt/DHODH-IN-1 (compound (R)-14d) is a potent, orally active dual inhibitor of RORγt (IC50: 0.083 μM) and DHODH (IC50: 0.172 μM), which exhibits significantFórmula:C24H26ClF6N3O3SForma y color:SolidPeso molecular:585.99Ep vinyl quinidine
CAS:<p>3-Epiquinine is a Quinidine stereoisomer, used in malaria, antiarrhythmic, inhibits P450db, and blocks K+ channels, IC50: 19.9 μM.</p>Fórmula:C20H24N2O2Forma y color:SolidPeso molecular:324.42GABAA receptor agonist 2
<p>Compound 4c, a potent GABAA agonist with anti-depressive effects in mouse FST/TST, shows promise in depression research.</p>Fórmula:C22H36O5Forma y color:SolidPeso molecular:380.52M826
<p>M826, a non-peptide, potent, selective, and reversible caspase-3 inhibitor, exhibits an IC50 of 0.005 μM and demonstrates strong anti-apoptotic activity in</p>Fórmula:C28H45N7O6Pureza:98%Forma y color:SolidPeso molecular:575.7Sinulatumolin E
CAS:<p>Sinulatumolin E, a terpenoid, inhibits TNF-α (IC 50: 3.6 μM); has anti-inflammatory properties.</p>Fórmula:C15H22O2Forma y color:SolidPeso molecular:234.33Carbonic anhydrase inhibitor 9
<p>Carbonic anhydrase inhibitor 9 targets hCA II and IX with Ki of 56.4 and 56.9 nM respectively; shows antiproliferative activity.</p>Fórmula:C22H20BrN5O4SForma y color:SolidPeso molecular:530.39AAA-10 formic
<p>AAA-10 formic is an orally active inhibitor of intestinal bacterial bile salt hydrolase (BSH) against B.</p>Fórmula:C26H43FO7SForma y color:SolidPeso molecular:518.68Chitin synthase inhibitor 1
<p>Potent, selective CHS inhibitor with 0.12 mM IC50; effective against drug-resistant fungi.</p>Fórmula:C22H20ClN3O3Forma y color:SolidPeso molecular:409.87PRMT5-IN-19
PRMT5-IN-19 is a potent, selective PRMT5 inhibitor with IC50 of 23.9 nM and 47 nM, showing anti-cancer activity by inducing apoptosis.Fórmula:C25H24N4OForma y color:SolidPeso molecular:396.48GAT564
<p>GAT564, an allosteric CB1R modulator, shows EC50s of 87 nM (cAMP) & 320 nM (β-arrestin2) and lowers IOP effectively in glaucoma mice.</p>Fórmula:C20H16N2O2SForma y color:SolidPeso molecular:348.42Dopamine D3 receptor antagonist-1
<p>Dopamine D3 receptor antagonist-1 is a dopamine D3 receptor selective or multi-targeting ligand with a Ki value of 1.58 nM that has demonstrated therapeutic</p>Fórmula:C31H35Cl2N3O3Forma y color:SolidPeso molecular:568.53MTL-CEBPA
<p>MTL-CEPBA is a small activating RNA that targets C/EBPα upregulation and exhibits anti-inflammatory and anti-cancer effects.</p>Forma y color:SolidAnticancer agent 29
<p>Compound E/Z-6f, anticancer, IC50: CDK2 (0.054 μM), CDK1 (0.127 μM), CDK4 (0.129 μM), CDK6 (0.396 μM).</p>Fórmula:C22H15ClFNOForma y color:SolidPeso molecular:363.81ASB14780
<p>ASB14780 is a 4-phenoxy derivative and an inhibitor of cytoplasmic phospholipase cPLA2α (IC50: 20 nM).</p>Forma y color:SolidEGFR/HER2-IN-4
<p>EGFR/HER2-IN-4: oral, irreversible dual EGFR inhibitor (IC50: 0.6 nM), targets L858R/T790M mutations, potent anti-lung cancer effects in vivo.</p>Forma y color:SolidEGFR-IN-35
CAS:<p>EGFR-IN-35, an acrylamide-based EGFR inhibitor, shows promise for EGFR mutation-related cancers like NSCLC.</p>Fórmula:C25H24ClN7O2Forma y color:SolidPeso molecular:489.96AChE/BACE1/GSK3β-IN-1
<p>AChE/BACE1/GSK3β-IN-1 is an orally active, blood-brain barrier-transparent, moderately bioavailable triple inhibitor of AChE/BACE1/GSK3β.</p>Fórmula:C26H27FN2O4Forma y color:SolidPeso molecular:450.5Antifungal agent 27
<p>Antifungal agent 27 shows moderate action against MRSA, weak against C. albicans, with MICs of 8 μg/mL and 32 μg/mL, respectively.</p>Fórmula:C18H23N5OSForma y color:SolidPeso molecular:357.47UB 165
CAS:<p>Subtype-selective nicotinic agonist</p>Fórmula:C13H15ClN2Pureza:98%Forma y color:SolidPeso molecular:234.72JAK3/BTK-IN-4
CAS:<p>JAK3/BTK-IN-4, a dual inhibitor for JAK3/BTK, shows synergy in autoimmune disease treatment. (Patent WO2021147953A1, compound 003)</p>Fórmula:C21H25ClN8OForma y color:SolidPeso molecular:440.93A1-Phytoprostane-I
CAS:<p>A1-Phytoprostane-I: cyclopentenone from α-linolenic acid in plants, induces gene expression & increases phytoalexin synthesis.</p>Fórmula:C18H28O4Forma y color:SolidPeso molecular:308.41Albicidin
CAS:<p>Albicidin is a DNA gyrase inhibitor produced by Xanthomonas albilineans.</p>Fórmula:C44H38N6O12Forma y color:SolidPeso molecular:842.818Cap-dependent endonuclease-IN-7
CAS:<p>Cap-dependent endonuclease-IN-7, a potent CEN inhibitor, blocks viral mRNA synthesis and virus spread, with research use for influenza A, B, C.</p>Fórmula:C36H28FN3O7SForma y color:SolidPeso molecular:665.69LRH-1 modulator-1
CAS:LRH-1 modulator-1: potent agonist, boosts IL-10, reduces IL-1b/TNFa, anti-inflammatory in gut.Fórmula:C28H36N2O2SForma y color:SolidPeso molecular:464.66HDAC6-IN-3
<p>HDAC6-IN-3 (Compound 14) is an oral anti-prostate cancer agent, inhibiting HDACs and MAO-A, with IC50 of 0.02-1.54 μM.</p>Fórmula:C19H27N3O3Forma y color:SolidPeso molecular:345.44FGFR4-IN-10
<p>FGFR4-IN-10 (compound 5a) is a potent, selective FGFR4 inhibitor with IC50 of 70.7 nM, sparing FGFR1-3.</p>Fórmula:C20H19F3N6O3Forma y color:SolidPeso molecular:448.4Spicamycin
CAS:<p>Spicamycin can be used as a potent inducer of differentiation of human myeloid leukemia cells (HL-60) and murine myeloid leukemia cells (M1).</p>Fórmula:C30H51N7O7Forma y color:SolidPeso molecular:621.77Keap1-Nrf2-IN-4
<p>Keap1-Nrf2-IN-4 hinders MGC-803 cell growth (IC50=2.55μM), migration, and induces apoptosis with low toxicity.</p>Fórmula:C26H34N2OForma y color:SolidPeso molecular:390.56Antitumor agent-74
<p>Antitumor agent-74, a quinazoline derivative, inhibits DNA, arrests cell cycle, and induces apoptosis with agent-75.</p>Fórmula:C26H23FN6Forma y color:SolidPeso molecular:438.5Dihydro-β-erythroidine hydrobromide
CAS:<p>Dihydro-β-erythroidine hydrobromide(DHβE) is a potent, oral active and competitive antagonist of neuronal nicotinic acetylcholine receptors (nAChRs).</p>Fórmula:C16H22BrNO3Pureza:98%Forma y color:White SolidPeso molecular:356.26FAK-IN-3
<p>FAK-IN-3 inhibits FAK, reduces PA-1 cell migration/invasion, and tumor growth, with no major side effects.</p>Fórmula:C28H28N6O4Forma y color:SolidPeso molecular:512.56RU 52583
CAS:<p>RU 52583 is an alpha 2-adrenergic receptor antagonist.</p>Fórmula:C18H20N2Pureza:98%Forma y color:SolidPeso molecular:264.36EICAR
CAS:<p>EICAR: IMP dehydrogenase inhibitor with anticancer and antiviral properties, failed in leukemia trials, active against various viruses but not SARS.</p>Fórmula:C11H13N3O5Forma y color:SolidPeso molecular:267.24ent-8-iso-15(S)-Prostaglandin F2α
CAS:<p>Isoprostanes are produced by the non-enzymatic, free radical peroxidation of phospholipid-esterified arachidonic acid.</p>Fórmula:C20H34O5Forma y color:SolidPeso molecular:354.48LasR-IN-1
<p>LasR-IN-1 (9g) strongly inhibits LasR, potent vs E. coli, with a 28.13 μM MIC against P. aeruginosa.</p>Fórmula:C23H21N3O2Forma y color:SolidPeso molecular:371.43Tubulin polymerization-IN-32
<p>Tubulin polymerization-IN-32: a cancer cell growth inhibitor used for research in cancers like lymphoma.</p>Fórmula:C29H30N2O7Forma y color:SolidPeso molecular:518.56LJ-4517
<p>LJ-4517 is an effective A2AAR antagonist (Ki=18.3 nM). LJ-4517 can effectively replace the binding of [3H] ZM241385 at WT A2AAR.</p>Fórmula:C19H21N5O3SForma y color:SolidPeso molecular:399.47FAAH/MAGL-IN-3
<p>FAAH/MAGL-IN-3 irreversibly inhibits FAAH (IC50: 179 nM) & MAGL (IC50: 759 nM) with low PAMPA permeability.</p>Fórmula:C21H25N3O6SForma y color:SolidPeso molecular:447.5QTX125 TFA
<p>QTX125 TFA: Potent, selective HDAC6 inhibitor with antitumor effects.</p>Fórmula:C25H20F3N3O7Forma y color:SolidPeso molecular:531.44JAK1/TYK2-IN-3
<p>JAK1/TYK2-IN-3, orally active, selectively inhibits TYK2 (IC50: 6 nM), JAK1 (37 nM), JAK2 (140 nM), JAK3 (362 nM), and has anti-inflammatory effects.</p>Forma y color:SolidBW-10
CAS:<p>BW-10 potently inhibits bombesin evoked release of gastrointestinal hormones in vitro and in vivo.</p>Fórmula:C57H72N14O8Forma y color:SolidPeso molecular:1081.27N-methyl Leukotriene C4
CAS:<p>N-methyl LTC4 is a stable synthetic analog of LTC4 and a selective CysLT2 agonist, useful in studying leukotriene pharmacology.</p>Fórmula:C31H49N3O9SForma y color:SolidPeso molecular:639.8FGFR4-IN-7
<p>FGFR4-IN-7 is a covalent, reversible FGFR4 inhibitor (IC50: 0.42 μM) that blocks the FGFR4 signaling pathway, thereby inducing apoptosis.</p>Fórmula:C26H25Cl2N5O3Forma y color:SolidPeso molecular:526.41c-Met-IN-2
CAS:<p>c-Met-IN-2 is a selective and orally available c-Met inhibitor (IC50: 0.6 nM) with antitumor activity.</p>Fórmula:C24H21FN10OPureza:98%Forma y color:SolidPeso molecular:484.49HDAC-IN-27
<p>HDAC-IN-27 is a potent and orally active inhibitor of HDAC Class I (0.43 nM - 3.01 nM for HDAC1-3).</p>Fórmula:C20H22N4O2Forma y color:SolidPeso molecular:350.41Kri 1314
CAS:Kri 1314 is a cyclohexyl-norstatine-containing dipeptide renin inhibitor which has potential for the treatment of hypertension.Fórmula:C38H51N5O7Forma y color:SolidPeso molecular:689.84PPO-IN-1
<p>PPO-IN-1 is a potent inhibitor of protoporphyrinogen IX oxidase (PPO) (Ki: 2.5 nM).</p>Fórmula:C18H10F3N3O4SForma y color:SolidPeso molecular:421.35PI3K-IN-37
CAS:<p>PI3K-IN-37 inhibits PI3K α/β/δ (IC50: 6/8/4 nM) and mTOR (IC50: 4 nM).</p>Fórmula:C25H26N6O2Forma y color:SolidPeso molecular:442.51PLP_Snyder530
<p>PLP_Snyder530, a potent PL pro inhibitor, halts SARS-CoV-2 by triggering protease conformation changes.</p>Fórmula:C24H24N2O2Forma y color:SolidPeso molecular:372.46Avibactam sodium dihydrate
<p>Avibactam sodium dihydrate (NXL-104) is a reversible covalent inhibitor for CTX-M-15 and TEM-1 β-lactamases with IC50s of 5 nM and 8 nM.</p>Fórmula:C7H14N3NaO8SForma y color:SolidPeso molecular:323.26Protease-Activated Receptor-1 antagonist 3
<p>PAR-1 antagonist 3: potent (IC50: 7 nM), binds hERG K+ channels (IC50: 9 μM).</p>Fórmula:C30H34N4O3Forma y color:SolidPeso molecular:498.62PI4KIIIbeta-IN-11
CAS:<p>PI4KIIIbeta-IN-11 is a PI4KIIIβ inhibitor (mean pIC50=9.1) that can be used to study diseases caused by RNA viruses and Plasmodium falciparum.</p>Fórmula:C33H39N7O3Forma y color:SolidPeso molecular:581.71Enpp-1-IN-12
<p>ENPP1-IN-12 is a potent, oral ENPP1 inhibitor with a Ki of 41 nM and anti-tumor properties.</p>Fórmula:C17H19N5O3SForma y color:SolidPeso molecular:373.43LXRβ agonist-2
CAS:LXRβ agonist-2 is a highly potent and β-selective liver X receptor (LXRβ) agonist with EC50 of 7 nM.Fórmula:C32H31F6N3O7Pureza:98%Forma y color:SolidPeso molecular:683.59CA IX-IN-1
<p>CA IX-IN-1 (compound 12g) is a potent and highly selective hCA IX inhibitor (IC50: 7 nM) that exhibits antitumour effects.</p>Fórmula:C16H22N4O8SForma y color:SolidPeso molecular:430.43MDK6465
CAS:<p>MDK6465 (PCSK9-IN-8b), CAS#1900686-46-5, is a liver-targeted PCSK9 synthesis inhibitor.</p>Fórmula:C27H29ClFN9O4Forma y color:SolidPeso molecular:598.03LP 12 hydrochloride hydrate
<p>LP 12 hydrochloride hydrate: potent, selective 5-HT7 agonist (Ki: 0.13 nM); less affinity for D2, 5-HT1A/2A receptors.</p>Fórmula:C32H39N3O·HCl·xH2OForma y color:SolidDifeterol
CAS:<p>Difeterol is a biochemical.</p>Fórmula:C25H29NO2Forma y color:SolidPeso molecular:375.50Fonsartan free acid
CAS:<p>Fonsartan: Angiotensin receptor blocker, halts angiotensin II effects on rat vascular cells.</p>Fórmula:C26H32N4O5S2Pureza:98%Forma y color:SolidPeso molecular:544.69SSTR4 agonist 4
CAS:<p>SSTR4 agonist 4, potent in pain research, shows promise in rodent pain models, with potential for Alzheimer's due to hippocampus activity.</p>Fórmula:C19H26N4OForma y color:SolidPeso molecular:326.44HER2-IN-9
<p>HER2-IN-9, an oral HER2 inhibitor (IC50: 0.03 μM), hinders growth and spread of HER2+ breast cancer.</p>Fórmula:C19H14BrF3N2OForma y color:SolidPeso molecular:423.23Dinordrin I diacetate
CAS:<p>Dinordrin I diacetate is an implantation inhibitor and hormone.</p>Fórmula:C25H32O4Pureza:98%Forma y color:SolidPeso molecular:396.52PD-1/PD-L1-IN-30
CAS:<p>PD-1/PD-L1-IN-30: Cancer research inhibitor with 0.018 μM IC50.</p>Fórmula:C29H28F3NO5Forma y color:SolidPeso molecular:527.53KU 59403
CAS:KU 59403 is an effective ATM inhibitor (IC50: 3 nM, 9.1 μM, and 10 μM for ATM, DNA-PK, and PI3K, respectively).Fórmula:C29H32N4O4S2Pureza:99.10%Forma y color:SolidPeso molecular:564.72Salacinol
CAS:<p>Salacinol is a naturally occurring alpha-glucosidase inhibitor isolated from an Ayurvedic traditional medicine Salacia reticulata.</p>Fórmula:C9H18O9S2Forma y color:SolidPeso molecular:334.37Substituted piperidines-1
CAS:<p>Substituted piperidines-1 can promote the release of growth hormone in humans and animals.</p>Fórmula:C29H39N7O2Pureza:98%Forma y color:SolidPeso molecular:517.67HIV-1 inhibitor-13
<p>HIV-1 inhibitor-13: oral NNRTI, IC50=0.14μM for HIV-1 RT, effective on resistant strains (EC50=2.85-18nM).</p>Fórmula:C30H32N6O3Forma y color:SolidPeso molecular:524.61Adiaft
CAS:<p>Adiaftis a bioactive chemical.</p>Fórmula:C10H11IN2O4Forma y color:SolidPeso molecular:350.11Enantiomer of Sofosbuvir
Inactive enantiomer of Sofosbuvir, used for chronic hepatitis C; lacks reported biological activity.Fórmula:C22H29FN3O9PPureza:98%Forma y color:SolidPeso molecular:529.45Aspochalasin M
CAS:<p>Aspochalasin M shows moderate activity on HL-60 cells (IC50=20.0 μ M). Aspochalasin M has research potential in leukemia diseases.</p>Fórmula:C24H35NO4Forma y color:SolidPeso molecular:401.542-Methylsorbinol
CAS:<p>2-Methylsorbinol is a bioactive chemical.</p>Fórmula:C12H11FN2O3Forma y color:SolidPeso molecular:250.23T-Type calcium channel inhibitor 2
<p>Compound 6g inhibits T-type Ca channels (IC50: Cav3.1-31μM, Cav3.2-83μM), cytotoxic to A549 (IC50: 5μM) & HCT-116 cells (IC50: 6.4μM).</p>Fórmula:C36H39FN4OSForma y color:SolidPeso molecular:594.78CY208-243 Mandelate
CAS:<p>CY208-243 is a D1 agonist boosting memory in T-maze, enhances adenylate cyclase (EC50=125nM), and alters monkey electroretinogram.</p>Fórmula:C27H26N2O3Forma y color:SolidPeso molecular:426.52BET-IN-1
<p>BET-IN-1 is a potent inhibitor of BET, exhibiting good brain permeability and a reasonable metabolic stability.</p>Fórmula:C23H24ClFN4O3SForma y color:SolidPeso molecular:490.98CK156
CAS:<p>CK156 inhibits DAPK with high selectivity; IC50: 182 nM (DRAK1), 34 μM (CK2a1), 39 μM (CK2a2); key in autoimmune/inflammation research.</p>Fórmula:C21H25N5O3Forma y color:SolidPeso molecular:395.45KRAS G12D inhibitor 3
CAS:<p>KRAS G12D Inhibitor 3, a compound targeting the KRAS G12D mutation, demonstrates potent antitumor efficacy with an inhibitory concentration (IC50) of less than</p>Fórmula:C34H31ClF3N5O2Forma y color:SolidPeso molecular:634.09GNE-203
CAS:<p>GNE-203 is a Met inhibitor.</p>Fórmula:C30H29Cl2F3N8O3Forma y color:SolidPeso molecular:677.50SGE-516
CAS:<p>SGE516: neuroactive steroid, enhances GABAA, lowers neuronal activity, protects from seizures.</p>Fórmula:C23H35N3O2Pureza:98%Forma y color:SolidPeso molecular:385.54Nnc 09-0026
CAS:<p>Nnc 09-0026 is a neuronal calcium channel blocker</p>Fórmula:C25H35Cl2F3N2OForma y color:SolidPeso molecular:507.46KFA1982
CAS:<p>KFA1982 is a novel and potent factor Xa inhibitor.</p>Fórmula:C28H34ClN3O9S2Forma y color:SolidPeso molecular:656.17HBV-IN-19 TFA
CAS:<p>HBV-IN19 TFA suppresses HBsAg, hampers HBV infection, and aids in HBV research.</p>Fórmula:C26H31F3N2O8Forma y color:SolidPeso molecular:556.53Zanapezil fumarate
CAS:<p>Zanapezil is an acetylcholinesterase (AChE) inhibitor. Zanapezil increases choline acetyltransferase activity in cultured rat septal cholinergic neurons.</p>Fórmula:C29H36N2O5Forma y color:SolidPeso molecular:492.61Multi-kinase-IN-1
CAS:<p>Multi-kinase-IN-1, a powerful kinase inhibitor, exhibits antitumor properties by inducing cell apoptosis.</p>Fórmula:C35H36F2N6O6SForma y color:SolidPeso molecular:706.76Elacestrant S enantiomer dihydrochloride
<p>Elacestrant (RAD1901) dihydrochloride, an oral ERR degrader, has IC50 of 48 nM (ERα) and 870 nM (ERβ). Its S enantiomer has low activity.</p>Fórmula:C30H40Cl2N2O2Pureza:98%Forma y color:SolidPeso molecular:531.56hDHODH-IN-10
<p>hDHODH-IN-10: selective oral inhibitor of hDHODH (IC50: 10.9 nM); blocks cancer cell growth, aids cancer research.</p>Fórmula:C21H15ClF4N2O4Forma y color:SolidPeso molecular:470.8MDK-3345
CAS:MDK-3345 is a reversible covalent inhibitor for Mcl-1.Fórmula:C36H34BN3O7Pureza:98%Forma y color:SolidPeso molecular:631.48SI-109
CAS:<p>SI-109 is a potent inhibitor of STAT3 SH2 domain (Ki=9 nM),and with antitumor activity.</p>Fórmula:C40H44F2N7O9PPureza:98%Forma y color:SolidPeso molecular:835.79PTP1B-IN-19
<p>PTP1B-IN-19, a benzimidazole, selectively inhibits protein tyrosine phosphatase 1B with a Ki of 23.3 μM, potential for type 2 diabetes research.</p>Fórmula:C26H19N3O4SForma y color:SolidPeso molecular:469.51FY-56
<p>FY-56: potent, selective LSD1/KDM1A inhibitor (IC50=42nM); differentiates MOLM-13/MV4-11 cells; promising for AML research.</p>Fórmula:C23H19FN2O3Forma y color:SolidPeso molecular:390.41G092
<p>G092 is a potent inhibitor of MsbA. MsbA is an ABC transporter protein. G092 has potential for antibacterial drug research.</p>Fórmula:C23H20Cl2N2O3Forma y color:SolidPeso molecular:443.32SCP1-IN-1
CAS:<p>SCP1-IN-1 (SH T-62) is a potent inhibitor of SCP1, promoting REST degradation and potentially aiding glioblastoma research.</p>Fórmula:C20H19F3N2O7S2Pureza:99.53%Forma y color:SoildPeso molecular:520.5RTIOX-372
CAS:<p>RTIOX-372 is a potent and selective orexin-1 receptor antagonist.</p>Fórmula:C30H39N5O3Forma y color:SolidPeso molecular:517.66Pomaglumetad methionil
CAS:<p>Pomaglumetad methionil is an oral methionine prodrug of the potent specific agonist of mGlu2/3 receptor LY404039.</p>Fórmula:C12H20N2O8S2Pureza:98%Forma y color:SolidPeso molecular:384.43ATX inhibitor 12
<p>Oral ATX inhibitor 12 (IC50: 1.72 nM) at 60 mg/kg prevents lung damage in C57Bl/6J mice.</p>Fórmula:C30H34FN5O2Forma y color:SolidPeso molecular:515.62LRRK2-IN-2
CAS:<p>LRRK2-IN-2: selective, potent LRRK2 inhibitor, IC50 of 0.6 nM, oral, crosses blood-brain barrier, for Parkinson's research.</p>Fórmula:C23H23Cl2F3N6O2Forma y color:SolidPeso molecular:543.37Everafenib
<p>Everafenib: potent BRAF inhibitor, crosses blood-brain barrier, hinders MAPK, effective on V600EBRAF cells, outperforms other drugs in trials.</p>Fórmula:C20H23ClFN5O2S2Forma y color:SolidPeso molecular:484.01KRAS G12C inhibitor 37
CAS:<p>KRAS G12C inhibitor 37 targets a key signaling protein, showing promise for cancer research involving KRAS G12C.</p>Fórmula:C35H39F3N8O2Forma y color:SolidPeso molecular:660.73MrgprX2 antagonist-7
<p>MrgprX2 antagonist-7 is an anti-allergic agent with significant anti-allergic effects and inhibits mast cell degranulation.</p>Fórmula:C24H22ClF3N6O3Forma y color:SolidPeso molecular:534.92MK-8318
CAS:<p>MK-8318 is an effective and selective antagonist of the CRTh2 receptor (Ki: 5.0 nM).</p>Fórmula:C27H26F4N2O5Pureza:98%Forma y color:SolidPeso molecular:534.5ATP synthase inhibitor 2
CAS:<p>ATP synthase inhibitor 2 blocks P. aeruginosa ATP synthase; IC50=10 μg/mL, fully inhibits at 128 μg/mL.</p>Fórmula:C21H22N2O3SForma y color:SolidPeso molecular:382.48IACS-8779 disodium
CAS:<p>IACS-8779 disodium: potent STING agonist, strong systemic anti-tumor effects, effective in melanoma model.</p>Fórmula:C21H23N9Na2O10P2S2Forma y color:SolidPeso molecular:733.52Dyrk1A/α-synuclein-IN-2
<p>Dyrk1A/α-synuclein-IN-2 (Compound b20) is a dual inhibitor of Dyrk1A and α-synuclein aggregation that acts on α-synuclein (IC50: 7.8 μM).</p>Fórmula:C21H16N4O4SForma y color:SolidPeso molecular:420.44Antitubulin agent 1
<p>Antitubulin agents-1 disrupts microtubules, ups α-tubulin acetylation, and has anticancer properties.</p>Fórmula:C21H19N3O3Forma y color:SolidPeso molecular:361.39TRPC5-IN-4
CAS:<p>TRPC5-IN-4: Potent, safe inhibitor; IC50 14.07 nM (TRPC5), 65 nM (TRPC4); non-toxic to liver/kidney cells; for CKD research.</p>Fórmula:C18H11ClF4N4O3Forma y color:SolidPeso molecular:442.75AKR1C3-IN-7
<p>AKR1C3-IN-7 (Compound 13) is an effective and selective AKR1C3 inhibitor (IC50=0.19 μM). AKR1C3-IN-7 has antitumor activity.</p>Fórmula:C24H20N2O4Forma y color:SolidPeso molecular:400.43IMR687
CAS:<p>IMR687: a PDE9 inhibitor that could improve memory in Alzheimer's by slowing cGMP hydrolysis.</p>Fórmula:C21H26N6O2Pureza:98%Forma y color:SolidPeso molecular:394.47EFdA-TP tetrasodium
CAS:<p>EFdA-TP tetrasodium is a potent HIV-1 inhibitor that blocks DNA synthesis as an ICT or DCT.</p>Fórmula:C12H11FN5Na4O12P3Pureza:98%Forma y color:SolidPeso molecular:621.12Aurora A inhibitor 1
CAS:<p>Aurora A inhibitor 1: potent, selective, targets cancer-linked Aurora A overexpression, potential for cancer research. (WO2021147974A1, 49)</p>Fórmula:C25H28ClF2N5O2Forma y color:SolidPeso molecular:503.97PIKfyve-IN-1
<p>PIKfyve-IN-1: potent, cell-active inhibitor for PIKfyve research, IC50=6.9 nM.</p>Fórmula:C20H21N5Forma y color:SolidPeso molecular:331.41HIF-2α-IN-5
CAS:<p>HIF-2α-IN-5 is a potent HIF-2α inhibitor with an IC 50 of < 50 nM [1].</p>Fórmula:C15H12F4O3S2Forma y color:SolidPeso molecular:380.38Anticancer agent 26
<p>Anticancer agent 26 is a promising candidate for cancer therapy and deserves further development.</p>Fórmula:C28H33NO5Forma y color:SolidPeso molecular:463.57MRS2179 tetrasodium hydrate
<p>MRS2179 blocks turkey P2Y1 receptor (Kb 102 nM, pA2 6.99), affects platelet aggregation, and has varying IC50s on P2 receptors.</p>Fórmula:C11H15N5Na4O10P2Forma y color:SolidPeso molecular:576.21AZ12971554
<p>AZ12971554: Human thrombin inhibitor, Ki=0.3nM; APTT IC50=0.68µM; ECT IC50=0.16µM.</p>Fórmula:C20H17ClFN7O3Forma y color:SolidPeso molecular:457.85Flusoxolol
CAS:<p>Flusoxolol is a beta-adrenoceptor partial agonist.</p>Fórmula:C22H30FNO4Forma y color:SolidPeso molecular:391.48Zorubicin
CAS:<p>Zorubicin, a Daunorubicin derivative, targets topoisomerase II, inhibits DNA polymerase, and researches acute leukemia, sarcomas.</p>Fórmula:C34H35N3O10Forma y color:SolidPeso molecular:645.66SB 243213 dihydrochloride
CAS:<p>SB 243213 dihydrochloride is an orally active, selective and high-affinity antagonist of 5-hydroxytryptamine (5-HT)2C receptor(pKi of 9.37 and a pKb of 9.8 for</p>Fórmula:C22H21Cl2F3N4O2Pureza:98%Forma y color:SolidPeso molecular:501.33TT15
CAS:<p>TT15 is an agonist of the GLP-1R.</p>Fórmula:C51H44Cl2N4O6Forma y color:SolidPeso molecular:879.82AZ-PFKFB3-67 quarterhydrate
<p>AZ-PFKFB3-67 quarterhydrate inhibits PFKFB3 (IC50: 11 nM), PFKFB2 (159 nM), and PFKFB1 (1130 nM).</p>Fórmula:C26H27N5O4Forma y color:SolidPeso molecular:460.01FNC-TP trisodium
<p>FNC-TP trisodium, active intracellular FNC form, inhibits NRTI, fights HIV, HBV, and HCV.</p>Fórmula:C9H11FN6Na3O13P3Forma y color:SolidPeso molecular:592.11BRD7929
CAS:<p>BRD7929 is a multistage antimalarial inhibitor for single-dose treatment of malaria in mouse models.</p>Fórmula:C33H38N4O2Forma y color:SolidPeso molecular:522.68PF-07202954
CAS:<p>PF-07202954, a weakly basic diacylglycerol O-acyltransferase 2 (DGAT2) inhibitor, exhibits an inhibition concentration half-maximum (IC50) of 10 nM against</p>Fórmula:C22H23FN6O3Pureza:98%Forma y color:SolidPeso molecular:438.45ZK168281
CAS:<p>ZK168281 is a 1α,25(OH)2D3 analog, VDR antagonist with 0.1 nM Kd, and blocks receptor CoA interaction.</p>Fórmula:C32H46O5Pureza:98%Forma y color:SolidPeso molecular:510.70BGC-638
CAS:<p>BGC-638, an analogue of BGC-945, is a thymidylate synthase inhibitor specifically transported into α-folate receptor (α-FR)–overexpressing tumors.</p>Fórmula:C32H33N5O9Forma y color:SolidPeso molecular:631.63Ketomethylenebestatin
CAS:<p>Ketomethylenebestatin, a weaker carba-analog of aminopeptidase inhibitor bestatin, is 10x less potent.</p>Fórmula:C17H25NO4Pureza:98%Forma y color:SolidPeso molecular:307.38PF-06305591 dihydrate
<p>PF-06305591 dihydrate is a potent and highly selective voltage gated sodium channel NaV1.8 blocker (IC 50 = 15 nM) with an excellent preclinical in vitro ADME</p>Fórmula:C15H26N4O3Forma y color:SolidPeso molecular:310.39CBP/p300-IN-16
<p>CBP/p300-IN-16 (compound 1) is a potent inhibitor of EP300/CBP HAT, acting on HAT EP300 (IC50: 0.61 μM) and LK2 H3K27 (IC50: 2.24 μM).</p>Fórmula:C26H31N3O4Forma y color:SolidPeso molecular:449.54CI 922
CAS:<p>CI 922 is an anaphylaxis mediator release inhibitor. It inhibits the activation of human neutrophils.</p>Fórmula:C26H30N10O6Forma y color:SolidPeso molecular:578.58SARS-CoV-2-IN-8
<p>SARS-CoV-2-IN-8 is a major protease inhibitor of SARS-CoV-2 (IC50: 0.75 μM).</p>Fórmula:C35H38N6O3Forma y color:SolidPeso molecular:590.71NBTIs-IN-5
CAS:<p>NBTIs-IN-5 inhibits Mycobacterium abscessus DNA with IC50 1.5μM, halts growth at MIC90 0.4μM.</p>Fórmula:C24H25F3N4O2Forma y color:SolidPeso molecular:458.48RdRP-IN-4
<p>RdRP-IN-4, an oral arylbenzohydrazide, inhibits influenza A/B by targeting PB1 of RdRP, with EC50s of 53 nM (H1N1) and 20 nM (Flu B), and aids infected mice.</p>Fórmula:C17H17Br2N3O2Forma y color:SolidPeso molecular:455.14(E)-10-Hydroxynortriptyline maleate
CAS:<p>(E)-10-Hydroxy Nortriptyline maleate, a derivative of antidepressant Nortriptyline, eases depression symptoms.</p>Fórmula:C23H25NO5Pureza:98%Forma y color:SolidPeso molecular:395.455PS-519
CAS:<p>PS-519 is a human tissue plasminogen activator and proteasome inhibitor.</p>Fórmula:C12H19NO4Forma y color:SolidPeso molecular:241.28FTO-IN-6
CAS:<p>FTO-IN-6 is a selective inhibitor of fat mass and obesity associated protein (FTO).</p>Fórmula:C14H12N4O6Forma y color:SolidPeso molecular:332.27hCAIX/XII-IN-1
<p>hCAIX/XII-IN-1: potent CAIX inhibitor (KI=0.48μM), CAXII (KI=0.83μM), antiproliferative, induces apoptosis in MCF-7 cells.</p>Fórmula:C19H11NO5S2Forma y color:SolidPeso molecular:397.42L-Moses dihydrochloride
<p>L-Moses (L-45) dihydrochloride is the first, potent, selective p300/CBP-associated factor (PCAF) bromodomain (Brd) inhibitor (Kd: 126 nM).</p>Fórmula:C21H26Cl2N6Forma y color:SolidPeso molecular:433.38EGFR-IN-58
<p>EGFR-IN-58 is a potent, selective, ATP-competitive inhibitor of EGFR. EGFR-IN-58 exhibits significant cytotoxicity against melanoma, colon and blood cancers.</p>Fórmula:C31H30FN7OForma y color:SolidPeso molecular:535.61COX-2-IN-13
<p>COX-2-IN-13 is a potent, selective COX-2 inhibitor with 0.98 μM IC50; shows strong anti-inflammatory properties and low acute toxicity.</p>Fórmula:C19H18N2O5SForma y color:SolidPeso molecular:386.42AN-12-H5
CAS:<p>AN-12-H5 is an anti-enteroviral compound that targets the replication process of PV and EV71 viruses.</p>Fórmula:C24H23N3O4S3Forma y color:SolidPeso molecular:513.65LolCDE-IN-2
CAS:<p>LolCDE-IN-2 is a potent Lol protein (LolCDE) inhibitor. LolCDE-IN-2 shows antibacterial activity with a MIC of 2 μg/ml against E. coli MG1655 [1].</p>Fórmula:C22H17N5OPureza:98%Forma y color:SolidPeso molecular:367.40LPA5 antagonist 2
<p>LPA5 antagonist 2, compound 65, water-soluble, reduces nociception, for inflammatory/neuropathic pain study.</p>Fórmula:C26H25FN2O4SForma y color:SolidPeso molecular:480.55Saphenamycin
CAS:<p>Saphenamycin is an antibiotic from a strain of Streptomyces.</p>Fórmula:C23H18N2O5Pureza:98%Forma y color:SolidPeso molecular:402.40ChE/Aβ1-42-IN-1
<p>ChE/Aβ1-42-IN-1 (compound 28) is a potent aggregation inhibitor of ChE and Aβ 1-42 with excellent BBB permeability.</p>Fórmula:C19H24N2O3Forma y color:SolidPeso molecular:328.41Desacetylravidomycin
CAS:<p>Desacetylravidomycin is a new inhibitor of IL-4 signal transduction, produced by Streptomyces sp. WK-6326.</p>Fórmula:C29H31NO8Forma y color:SolidPeso molecular:521.56GRP78-IN-1
<p>GRP78-IN-1 binds to GRP78 protein, inhibits cell growth, and triggers apoptosis in breast cancer; has -8.07 kcal/mol binding energy.</p>Fórmula:C21H23FO3Forma y color:SolidPeso molecular:342.4XIAP/cIAP1 antagonist-1
<p>Potent oral XIAP/cIAP1 inhibitor with EC50s: XIAP 5.1 nM, cIAP1 0.32 nM; curbs tumor growth in vivo.</p>Forma y color:SolidGlycotriosyl glutamine
CAS:<p>Glycotriosyl glutamine is a nephritogenoside analog.</p>Fórmula:C23H40N2O18Forma y color:SolidPeso molecular:632.57DS17701585
<p>DS17701585: Oral EP300/CBP inhibitor; potent on CBP, EP300, H3K27, & SOX2; useful for cancer research.</p>Fórmula:C24H26N4O5SForma y color:SolidPeso molecular:482.55Complex III-IN-1
<p>Complex III-IN-1 inhibits complex III, has antifungal properties, and an EC50 of 18.53 mg/L against S. sclerotiorum.</p>Fórmula:C14H20ClNO2S2Forma y color:SolidPeso molecular:333.9VEGFR-2-IN-25
CAS:<p>VEGFR-2-IN-25 (compound 5d) is a potent inhibitor of VEGFR-2 (IC50: 12.1 nM).</p>Fórmula:C24H22N6O2Forma y color:SolidPeso molecular:426.47Myxothiazol
CAS:<p>Myxothiazol blocks mitochondrial complex III and triggers SESN2, a gene important for stress response.</p>Fórmula:C25H33N3O3S2Forma y color:SolidPeso molecular:487.68KP 10614
CAS:<p>KP 10614 is a new prostacyclin analog that inhibits platelet-polymorphonuclear leukocyte interaction.</p>Fórmula:C23H32O4Forma y color:SolidPeso molecular:372.50Furaprevir
CAS:<p>Furaprevir is an HCV NS3/4A Inhibitor</p>Fórmula:C47H56N6O10SForma y color:SolidPeso molecular:897.05HDAC1-IN-3
<p>HDAC1-IN-3 is a potent inhibitor of Pf HDAC1.</p>Fórmula:C22H24ClN7O2Forma y color:SolidPeso molecular:453.92Fusarochromanone
CAS:Fusarochromanone (FC-101) is a mycotoxin produced by Fusarium oxysporum with potent antiangiogenic, anticancer and antimalarial activities.Fórmula:C15H20N2O4Pureza:95.31% - 96%Forma y color:SolidPeso molecular:292.33L 702007
CAS:<p>L 702007 is an inhibitor of HIV-1 reverse transcriptase.</p>Fórmula:C18H25N3O2Pureza:98%Forma y color:SolidPeso molecular:315.41APN/AKT-IN-1
<p>APN/AKT-IN-1, a dual APN (IC50=0.21μM) & AKT (IC50=0.27μM) inhibitor, hinders GSK3β phosphorylation.</p>Fórmula:C18H27N7O3Forma y color:SolidPeso molecular:389.45
